Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy, Partial

Interventions

DRUG: Seletracetam (ucb 44212)

Sponsor

UCB S.A. - Pharma Sector